Addressing Common Medications That Influence Immunotherapy Response in Solid Tumors.
Publication
, Journal Article
DeVito, N; Gray, E; Schrum, D; Antonia, S
Published in: J Clin Oncol
January 7, 2026
Duke Scholars
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
January 7, 2026
Start / End Page
JCO2501811
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
DeVito, N., Gray, E., Schrum, D., & Antonia, S. (2026). Addressing Common Medications That Influence Immunotherapy Response in Solid Tumors. J Clin Oncol, JCO2501811. https://doi.org/10.1200/JCO-25-01811
DeVito, Nicholas, Erica Gray, Daniel Schrum, and Scott Antonia. “Addressing Common Medications That Influence Immunotherapy Response in Solid Tumors.” J Clin Oncol, January 7, 2026, JCO2501811. https://doi.org/10.1200/JCO-25-01811.
DeVito N, Gray E, Schrum D, Antonia S. Addressing Common Medications That Influence Immunotherapy Response in Solid Tumors. J Clin Oncol. 2026 Jan 7;JCO2501811.
DeVito, Nicholas, et al. “Addressing Common Medications That Influence Immunotherapy Response in Solid Tumors.” J Clin Oncol, Jan. 2026, p. JCO2501811. Pubmed, doi:10.1200/JCO-25-01811.
DeVito N, Gray E, Schrum D, Antonia S. Addressing Common Medications That Influence Immunotherapy Response in Solid Tumors. J Clin Oncol. 2026 Jan 7;JCO2501811.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
January 7, 2026
Start / End Page
JCO2501811
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences